{{Chembox
| ImageFile = Asunaprevir.svg
| IUPACName = 3-Methyl-''N''-{[(2-methyl-2-propanyl)oxy]carbonyl}-<small>L</small>-valyl-(4''R'')-4-[(7-chloro-4-methoxy-1-isoquinolinyl)oxy]-''N''-{(1''R'',2''S'')-1-[(cyclopropylsulfonyl)carbamoyl]-2-vinylcyclopropyl}-<small>L</small>-prolinamide
| OtherNames = BMS-650032
|Section1={{Chembox Identifiers
| CASNo = 630420-16-5
| CASNo_Ref = {{cascite|correct|}}
| PubChem = 16076883
| ChemSpiderID = 17235944
| ChEMBL = 2105735
| KEGG = D10093
| KEGG_Ref = {{keggcite|correct|kegg}}
| SMILES = O=C(N5[C@H](C(=O)N[C@@]2(C(=O)NS(=O)(=O)C1CC1)[C@H](\C=C)C2)C[C@@H](Oc3ncc(OC)c4c3cc(Cl)cc4)C5)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C
| InChI = 1/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1
| InChIKey = XRWSZZJLZRKHHD-WVWIJVSJBJ
| StdInChI = 1S/C35H46ClN5O9S/c1-9-19-16-35(19,31(44)40-51(46,47)22-11-12-22)39-28(42)25-15-21(49-29-24-14-20(36)10-13-23(24)26(48-8)17-37-29)18-41(25)30(43)27(33(2,3)4)38-32(45)50-34(5,6)7/h9-10,13-14,17,19,21-22,25,27H,1,11-12,15-16,18H2,2-8H3,(H,38,45)(H,39,42)(H,40,44)/t19-,21-,25+,27-,35-/m1/s1
| StdInChIKey = XRWSZZJLZRKHHD-WVWIJVSJSA-N
  }}
|Section2={{Chembox Properties
| C=35 | H=46 | Cl=1 | N=5 | O=9 | S=1
| Appearance = 
| Density = 
| MeltingPt = 
| BoilingPt = 
| Solubility =
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = J05
| ATCCode_suffix = AE15
}}
|Section7={{Chembox Hazards
| MainHazards = 
| FlashPt = 
| AutoignitionPt =
  }}
}}

'''Asunaprevir''' (formerly '''BMS-650032''', brand name in [[Japan]] and [[Russia]]<ref>{{cite web|title=Sunvepra™ (asunaprevir) soft gelatin capsules 100 mg. Registration certificate|url=http://grls.rosminzdrav.ru/Grls_View_v2.aspx?idReg=374742&t=|website=State Register of Medicines|accessdate=26 August 2015|language=Russian}}</ref> '''Sunvepra''') is an experimental drug candidate for the treatment of [[hepatitis C]]. It is undergoing [[drug development|development]] by [[Bristol-Myers Squibb]] and is currently in [[Phase III clinical trials]].<ref>{{cite web | url = http://clinicaltrials.gov/ct2/show/NCT01497834 | title = A Phase 3 Study in Combination With BMS-790052 and BMS-650032 in Japanese Hepatitis C Virus (HCV) Patients | publisher = [[ClinicalTrials.gov]]}}</ref> 

Asunaprevir is an [[enzyme inhibitor|inhibitor]] of the [[hepatitis C virus]] enzyme [[NS3 (HCV)|serine protease NS3]].<ref>{{cite journal | title = Asunaprevir. HCV serine protein NS3 inhibitor, Treatment of hepatitis C virus | author = C. Reviriego | journal = Drugs of the Future | year = 2012 | volume = 37 | issue = 4 | pages = 247–254 | doi = 10.1358/dof.2012.37.4.1789350 | url = https://journals.prous.com/journals/servlet/xmlxsl/pk_journals.xml_summary_pr?p_JournalId=2&p_RefId=1789350&p_IsPs=N}}</ref>

Asunaprevir is being tested in combination with [[pegylated interferon]] and [[ribavirin]], as well as in interferon-free regimens with other direct-acting antiviral agents including [[daclatasvir]].<ref>{{cite journal | last1 = Lok | first1 = A | display-authors = etal   | year = 2012 | title = Preliminary Study of Two Antiviral Agents for Hepatitis C Genotype 1 | url = http://www.nejm.org/doi/full/10.1056/NEJMoa1104430 | journal = New England Journal of Medicine | volume = 366 | issue = 3| pages = 216–224 | doi=10.1056/NEJMoa1104430}}</ref><ref>{{cite web | url = https://www.bloomberg.com/news/2012-04-19/bristol-myers-daclatasvir-asunaprevir-cured-77-study.html | title = Bristol-Myers' Daclatasvir, Asunaprevir Cured 77%: Study | publisher = ''[[Bloomberg L.P.|Bloomberg]]'' | date = Apr 19, 2012}}</ref><ref>[http://www.hivandhepatitis.com/hepatitis-c/hepatitis-c-topics/hcv-treatment/3337-aasld-daclatasvir-plus-asunaprevir-rapidly-suppresses-hcv-in-prior-null-responders AASLD: Daclatasvir plus Asunaprevir Rapidly Suppresses HCV in Prior Null Responders]. Highleyman, L. HIVandHepatitis.com. 8 November 2011.</ref>

==See also==
* [[Boceprevir]]
* [[Telaprevir]]

==References==
{{reflist}}

{{RNA antivirals}}

[[Category:Carbamates]]
[[Category:Chloroarenes]]
[[Category:Cyclopropanes]]
[[Category:Experimental drugs]]
[[Category:Isoquinolines]]
[[Category:NS3/4A protease inhibitors]]
[[Category:Pyrrolidines]]
[[Category:Sulfonamides]]
[[Category:Tert-butyl compounds]]

{{Antiinfective-drug-stub}}